(Aviation attorney) Eli Lilly and Co. v. Teva Pharm. USA., Inc.
More info…
(U.S. Fed. Cir., Drugs & Biotech, Intellectual Property, Patent) In a patent infringement action related to a drug for the treatment and prevention of postmenopausal osteoporosis, the district court’s order in favor of plaintiff is affirmed where the court did not abuse its discretion in extending a statutory thirty-month stay preventing the FDA from approving defendant’s new drug application due to defendant’s discovery violations.
Tags: Florida Lawyer
External articles | SEO-FSER | 
March 18, 2009 5:45 pm
No Comments
No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
You must be logged in to post a comment.
Subscribe